Exact Sciences logo

EXAS - Exact Sciences News Story

$123.83 3.3  2.8%

Last Trade - 30/10/20

Sector
Healthcare
Size
Large Cap
Market Cap £14.83bn
Enterprise Value £15.05bn
Revenue £1.02bn
Position in Universe 467th / 6403

BRIEF-Exact Sciences Q2 Loss Per Share $0.58

Thu 30th July, 2020 9:25pm
July 30 (Reuters) - Exact Sciences Corp  EXAS.O :
    * Q2 LOSS PER SHARE $0.58
    * EXACT SCIENCES ANNOUNCES SECOND QUARTER 2020 RESULTS
    * Q2 REVENUE $268.9 MILLION VERSUS REFINITIV IBES ESTIMATE
OF
$228.4 MILLION
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.63 -- REFINITIV IBES
DATA

Source text for Eikon:  ID:nPn6xT1RTa 
Further company coverage:  EXAS.O 

 ((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.